Amgen Inc (AMGN)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	63,170,000	59,040,000	59,377,000	60,761,000	37,354,000	37,161,000	35,705,000	36,010,000	33,222,000	33,291,000	28,458,000	31,129,000	32,895,000	34,196,000	34,133,000	30,008,000	26,950,000	27,742,000	27,798,000	29,319,000
Total assets	US$ in thousands	97,154,000	90,534,000	90,269,000	88,720,000	65,121,000	63,700,000	59,294,000	59,196,000	61,165,000	64,993,000	59,773,000	62,539,000	62,948,000	64,637,000	65,011,000	61,669,000	59,707,000	59,535,000	59,373,000	63,997,000
Debt-to-assets ratio		0.65	0.65	0.66	0.68	0.57	0.58	0.60	0.61	0.54	0.51	0.48	0.50	0.52	0.53	0.53	0.49	0.45	0.47	0.47	0.46

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $63,170,000K ÷ $97,154,000K
= 0.65

The debt-to-assets ratio of AMGEN Inc. has shown a slight increase from 0.60 in Q4 2022 to 0.67 in Q4 2023, indicating that the company has taken on more debt relative to its total assets during this period. The ratio remained relatively stable around 0.67 to 0.69 in the following quarters.

A higher debt-to-assets ratio suggests that a larger proportion of the company's assets is funded by debt, which could potentially increase financial risk. It is important for investors and creditors to monitor this ratio over time to assess the company's ability to meet its debt obligations and manage its financial leverage effectively.

Overall, the trend in AMGEN Inc.'s debt-to-assets ratio indicates a moderate increase in leverage over the past year, which may warrant further analysis to understand the company's financial health and sustainability.